GTPases function as molecular switches to control a wide variety of cellular processes including many involved in inflammation and cancer. Most of the signaling events that are regulated by GTPases take place on the cytoplasmic leaflet of cellular membranes. GTPases, which lack intrinsic hydrophobic domains, are targeted to this location by a series of post-translational modifications of a C-terminal CAAX motif that includes prenylation, proteolysis, and carboxyl methylation. Some GTPases are further modified by palmitoylation. The most significant accomplishments of the work performed over the course of the first four years of GM55279 are the molecular cloning of one of the enzymes that modifies Ras, prenylcysteine carboxyl methyltransferase (pcCMT) and the determination of its subcellular localization exclusively in the ER and Golgi, the paradigm-shifting studies of Ras trafficking that the latter observation provoked, and elucidation of membrane targeting of Rho GTPases. The current application seeks to shift the focus from the biology of GTPases in inflammatory cells to studies of membrane targeting GTPase in general.
The Specific Aims are: 1. Differential Tracking of H-Ras and K-Ras: using pulse-chase labeling and subcellular fractionation, microinjection followed by real-time imaging of fluorescent, initially unprocessed Ras proteins, dual color and dynamic (time-lapse, FRAP and FLIP) fluorescence analysis of GFP- tagged proteins, and S. cerevisiae mutants we will investigate the distinct pathways utilized by H- versus K-Ras; 2. Nuclear Targeting of Rac1: we will follow up on one of the unexpected and potentially significant observations of our Rho trafficking study, nuclear targeting of Rac1 masked by prenylation, by characterizing the cryptic nuclear localization signal and determining its functional relevance; 3. Ras Signaling on Intracellular Membranes: we will utilize GFP-Raf1-RBD, a novel reporter of Ras activation, to study Ras signaling events in situ in living cells and determine the kinetics, pathways and significance of signaling on internal membranes using a variety of systems, including C. elegans to assess in vivo the functional capacity of endomembrane-restricted Ras. The information gained from the proposed studies will not only help elucidate an important area of GTPase biology but they may give insights into drug development for the myriad of pathologic conditions, such as oncogenesis and inflammation, that are controlled, in part, by GTPases.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Marino, Pamela
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Fehrenbacher, Nicole; Tojal da Silva, Israel; Ramirez, Craig et al. (2017) The G protein-coupled receptor GPR31 promotes membrane association of KRAS. J Cell Biol 216:2329-2338
Zhou, Mo; Philips, Mark R (2017) Nitrogen Cavitation and Differential Centrifugation Allows for Monitoring the Distribution of Peripheral Membrane Proteins in Cultured Cells. J Vis Exp :
Court, Helen; Ahearn, Ian M; Amoyel, Marc et al. (2017) Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT. J Cell Biol 216:4165-4182
Zhou, Mo; Wiener, Heidi; Su, Wenjuan et al. (2016) VPS35 binds farnesylated N-Ras in the cytosol to regulate N-Ras trafficking. J Cell Biol 214:445-58
Tsai, Frederick D; Lopes, Mathew S; Zhou, Mo et al. (2015) K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif. Proc Natl Acad Sci U S A 112:779-84
Lynch, Stephen J; Snitkin, Harriet; Gumper, Iwona et al. (2015) The differential palmitoylation states of N-Ras and H-Ras determine their distinct Golgi subcompartment localizations. J Cell Physiol 230:610-9
Cox, Adrienne D; Der, Channing J; Philips, Mark R (2015) Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery? Clin Cancer Res 21:1819-27
Su, Wenjuan; Wynne, Joseph; Pinheiro, Elaine M et al. (2015) Rap1 and its effector RIAM are required for lymphocyte trafficking. Blood 126:2695-703
Tsai, Frederick D; Wynne, Joseph P; Ahearn, Ian M et al. (2014) Metabolic labeling of Ras with tritiated palmitate to monitor palmitoylation and depalmitoylation. Methods Mol Biol 1120:33-41
Court, Helen; Amoyel, Marc; Hackman, Michael et al. (2013) Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. J Clin Invest 123:4681-94

Showing the most recent 10 out of 15 publications